AMENDMENT TO NIAID RFA-AI-02-031 AND NIAID RFA-AI-02-050

RELEASE DATE:  December 30, 2002

NOTICE:  NOT-AI-03-005

National Institute of Allergy and Infectious Diseases (NIAID)

The purpose of this amendment is to clarify the requirement for an intellectual 
property plan mandated in "Article I., Subsection g. Intellectual Property Plan" 
and the "Supplemental Instructions" section of RFA AI-02-031 and RFA AI-02-050. 
The full RFAs are available at:
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-02-031.html and
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-02-050.html.

AMENDMENT

There is a critical public health need for the establishment of a highly 
developed research and development infrastructure with strong translational 
research capacity to implement the Biodefense Research Agenda of NIAID. The goal 
of the Regional Centers of Excellence for Biodefense and Emerging Infectious 
Diseases (RCE) program is to develop and maintain such an infrastructure and the 
associated research and development activities that will provide scientific 
information and translational research capacity to make the next generation of 
therapeutics, vaccines and diagnostics in defense of public health.  In order to 
assure that this information and research is made available in a timely manner, 
NIAID requires each applicant RCE or P-RCE (Planning Grants for RCEs) to develop 
and submit its own intellectual property plan.  This plan must address how the 
RCE or P-RCE and its collaborating parties will manage intellectual property 
generated under an award as well as other pertinent intellectual property 
matters in a manner consistent with timely commercialization of therapeutics, 
vaccines and diagnostics.

INQUIRIES

Inquiries regarding this notice may be directed to:

Dr. Rona Hirschberg
Division of Microbiology and Infectious Diseases, NIAID 
6610 Rockledge Dr., Room 5007, MSC 6605
Bethesda, MD 20892
Zip code for express couriers: 20817
Telephone:  301-402-8602
Fax: 301-480-1263
e-mail:  rhirschberg@niaid.nih.gov 

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.